Regeneron Pharmaceuticals (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Regeneron Pharmaceuticals" in English language version.

refsWebsite

Global rank English rank

13web.archive.org

1^st place

6regeneron.com

low place

4fda.gov

447^th place

338^th place

3biospace.com

low place

7,595^th place

2forbes.com

54^th place

48^th place

2nytimes.com

7^th place

2hhs.gov

5,973^rd place

3,693^rd place

2reuters.com

49^th place

47^th place

1sec.gov

572^nd place

436^th place

1bloomberg.com

99^th place

77^th place

1genengnews.com

low place

6,625^th place

1fiercebiotech.com

low place

8,828^th place

1barrons.com

2,737^th place

1,700^th place

1biopharmadive.com

low place

1ft.com

210^th place

157^th place

1sanofi.com

low place

1rocklandreport.com

low place

1bbc.com

20^th place

30^th place

1youtube.com

9^th place

13^th place

1ghostarchive.org

32^nd place

21^st place

1foxnews.com

152^nd place

120^th place

1washingtonpost.com

34^th place

27^th place

1twitter.com

23^rd place

32^nd place

1morningstar.com

low place

7,431^st place

1cnbc.com

220^th place

155^th place

1prnewswire.com

406^th place

258^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

1nascentbiotech.com

low place

1macrotrends.net

5,641^st place

4,405^th place

barrons.com

Hough, Jack (December 18, 2019). "10 Stocks That Had Better Decades Than Amazon and Google". Barron's. Archived from the original on December 18, 2019. Retrieved December 19, 2019.

bbc.com

Morelle, Rebecca (2020-09-14). "Antibody treatment to be given to Covid patients". BBC News. Retrieved 2020-10-08.

biopharmadive.com

Pagliarulo, Ned (February 4, 2020). "Regeneron partners with US government to develop coronavirus treatment". BioPharma Dive. Washington, D.C.: Industry Dive. Archived from the original on February 27, 2020. Retrieved July 25, 2021.

biospace.com

"Regeneron to Acquire Checkmate Pharmaceuticals and Its Investigational Immune Activator for Potential Use in Multiple Tumor Types" (Press release). Regeneron. April 19, 2022. Retrieved October 9, 2022 – via BioSpace.
"Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs". 9 August 2023.
"Novartis, Ono Latest to Announce Billion-Dollar M&A Deals". 5 March 2024.

bloomberg.com

"Sanofi-Regeneron Drug Lowers Cholesterol Up to 72% in Study". Bloomberg. 26 March 2012. Retrieved 25 July 2021.

clinicaltrials.gov

"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19". clinicaltrials.gov. 30 September 2020.

cnbc.com

Tirrell, Meg (2018-05-01). "A $14,000 cholesterol drug gets a price cut as Regeneron, Sanofi strike deal with Express Scripts". CNBC. Retrieved 2018-08-22.

fda.gov

"FDA approves Zaltrap for metastatic colorectal cancer" (Press release). U.S. Food and Drug Administration (FDA). August 3, 2012. Archived from the original on June 25, 2013.
"FDA approves Praluent to treat certain patients with high cholesterol" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on 2015-07-27. Retrieved 2015-07-29.
"FDA approves first treatment for advanced form of the second most common skin cancer". U.S. Food and Drug Administration (FDA) (Press release). 2019-09-11.
"FDA Approves First Treatment for Ebola Virus". U.S. Food and Drug Administration (FDA) (Press release). 14 October 2020. Retrieved 14 October 2020. This article incorporates text from this source, which is in the public domain.

fiercebiotech.com

Carroll, John (July 28, 2015). "UPDATED: Struggling Sanofi paying $1.8B to partner with Regeneron on immuno-oncology". FierceBiotech. Archived from the original on May 4, 2016. Retrieved October 9, 2022.

forbes.com

Herper, Matthew (August 14, 2013). "How Two Guys From Queens Are Changing Drug Discovery". Forbes. Archived from the original on March 16, 2014. Retrieved March 22, 2014.
"Regeneron's Billionaire Founder Battles The Drug Pricing System". Forbes. 26 July 2018. Retrieved 26 July 2018.

foxnews.com

"Trump taking Regeneron drug, Remdesivir therapy for coronavirus diagnosis: ex-WH doctor explains". Associated Press. Associated Press. 2020-10-03. Retrieved 2020-10-13.

ft.com

markets.ft.com

https://markets.ft.com/data/announce/full?dockey=1330-8992408en-4SB6JLTDIDJHOAC14KRIJ3Q6L8 ^{[bare URL]}

genengnews.com

Staff (July 28, 2015). "Regeneron, Sanofi Launch $2B+ Immuno-Oncology Collaboration". Genetic Engineering & Biotechnology News. Archived from the original on September 21, 2020. Retrieved October 9, 2022.

ghostarchive.org

Largacha, María Cecilia (6 August 2020). "2 ecuatorianos, cerca del medicamento contra el Covid-19". YouTube. Archived from the original on 2021-12-21. Retrieved 13 October 2020.

hhs.gov

News Division (4 February 2020). "HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment". HHS.gov. Archived from the original on 22 January 2021. Retrieved 8 October 2020.
News Division (6 July 2020). "HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment". HHS.gov. Archived from the original on 18 December 2020. Retrieved 8 October 2020.

macrotrends.net

"Regeneron Pharmaceuticals Revenue 2006–2021 | REGN". Stock Research. MacroTrends. Table (Regeneron Pharmaceuticals Annual Revenue). Retrieved July 26, 2021.

morningstar.com

Conover, Damien (January 19, 2021). "Biopharma Companies With COVID-19 Treatments See $10 Billion Market in 2021". Morningstar.com. Archived from the original on 2021-01-20. Retrieved 2021-01-19.

nascentbiotech.com

Susana Magadán Mompó and África González-Fernández. "Human Monoclonal Antibodies from Transgenic Mice". Chapter 13 in Human Monoclonal Antibodies: Methods and Protocols Ed. Michael Steinitz. Springer Science+Business Media, 2014. ISBN 978-1627035859

nytimes.com

Mazzucato, Mariana; Momenghalibaf, Azzi (March 18, 2020). "Drug Companies Will Make a Killing From Coronavirus". The New York Times. Archived from the original on March 18, 2020. Retrieved October 9, 2022.
"Regulators Approve a Drug for an Eye Condition". The New York Times. Associated Press. November 18, 2011.

prnewswire.com

"Regeneron and Sanofi Announce FDA Approval of Dupixent (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis" (Press release). Regeneron Pharmaceuticals Inc. – via PRNewswire.

regeneron.com

"Regeneron's COVID-19 Response Efforts". Regeneron Pharmaceuticals Inc. Retrieved 2020-10-08.
"Regeneron's COVID-19 Response Efforts". Regeneron Pharmaceuticals Inc.

investor.regeneron.com

Regeneron (7 July 2020). "Regeneron Announces Manufacturing and Supply Agreement for BARDA and U.S. Department of Defense for REGN-COV2 Anti-Viral Antibody Cocktail". Regeneron Pharmaceuticals Inc. Retrieved 2020-10-08.
"Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE Disease | Regeneron Pharmaceuticals Inc". August 18, 2023.

newsroom.regeneron.com

Regeneron (7 October 2020). "Statement on REGN-COV2 Emergency Use Authorization Request (PDF)". Regeneron Pharmaceuticals Inc. Retrieved 8 October 2020.
"Regeneron and Sanofi Announce FDA Approval of Kevzara (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients (NASDAQ:REGN)". Regeneron Pharmaceuticals Inc. (Press release).

reuters.com

Protard, Matthieu (May 25, 2020). "U.S.' Regeneron to buy back $5 billion stake held by Sanofi". Reuters. Ed. John Stonestreet. Archived from the original on October 18, 2020. Retrieved October 9, 2022.

uk.reuters.com

Kelland, Kate (2020-09-14). "Regeneron's antibody drug added to UK Recovery trial of COVID treatments". Reuters. Archived from the original on September 17, 2020. Retrieved 2020-10-08.

rocklandreport.com

Regeneron Pharmaceuticals Purchases Avon in Suffern For $38.875 Million, To be Used For Research & Development Laboratories

sanofi.com

"Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration". Sanofi. May 25, 2020. Retrieved February 17, 2023.

sec.gov

"Regeneron Pharmaceuticals, Inc. 2023 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. February 5, 2024.

twitter.com

Trump, Donald (7 October 2020). "A Message From The President!". Twitter. Retrieved 7 October 2020.

washingtonpost.com

Cunningham, Paige Winfield. "Analysis | The Health 202: Trump is taking Regeneron's new coronavirus treatment. It's used for mild symptoms" – via www.washingtonpost.com.

web.archive.org

Herper, Matthew (August 14, 2013). "How Two Guys From Queens Are Changing Drug Discovery". Forbes. Archived from the original on March 16, 2014. Retrieved March 22, 2014.
Staff (July 28, 2015). "Regeneron, Sanofi Launch $2B+ Immuno-Oncology Collaboration". Genetic Engineering & Biotechnology News. Archived from the original on September 21, 2020. Retrieved October 9, 2022.
Carroll, John (July 28, 2015). "UPDATED: Struggling Sanofi paying $1.8B to partner with Regeneron on immuno-oncology". FierceBiotech. Archived from the original on May 4, 2016. Retrieved October 9, 2022.
Hough, Jack (December 18, 2019). "10 Stocks That Had Better Decades Than Amazon and Google". Barron's. Archived from the original on December 18, 2019. Retrieved December 19, 2019.
Mazzucato, Mariana; Momenghalibaf, Azzi (March 18, 2020). "Drug Companies Will Make a Killing From Coronavirus". The New York Times. Archived from the original on March 18, 2020. Retrieved October 9, 2022.
Pagliarulo, Ned (February 4, 2020). "Regeneron partners with US government to develop coronavirus treatment". BioPharma Dive. Washington, D.C.: Industry Dive. Archived from the original on February 27, 2020. Retrieved July 25, 2021.
Protard, Matthieu (May 25, 2020). "U.S.' Regeneron to buy back $5 billion stake held by Sanofi". Reuters. Ed. John Stonestreet. Archived from the original on October 18, 2020. Retrieved October 9, 2022.
News Division (4 February 2020). "HHS, Regeneron Collaborate to Develop 2019-nCoV Treatment". HHS.gov. Archived from the original on 22 January 2021. Retrieved 8 October 2020.
Kelland, Kate (2020-09-14). "Regeneron's antibody drug added to UK Recovery trial of COVID treatments". Reuters. Archived from the original on September 17, 2020. Retrieved 2020-10-08.
News Division (6 July 2020). "HHS, DOD Collaborate with Regeneron on Large-Scale Manufacturing Demonstration Project of COVID-19 Investigational Therapeutic Treatment". HHS.gov. Archived from the original on 18 December 2020. Retrieved 8 October 2020.
Conover, Damien (January 19, 2021). "Biopharma Companies With COVID-19 Treatments See $10 Billion Market in 2021". Morningstar.com. Archived from the original on 2021-01-20. Retrieved 2021-01-19.
"FDA approves Zaltrap for metastatic colorectal cancer" (Press release). U.S. Food and Drug Administration (FDA). August 3, 2012. Archived from the original on June 25, 2013.
"FDA approves Praluent to treat certain patients with high cholesterol" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on 2015-07-27. Retrieved 2015-07-29.

youtube.com

Largacha, María Cecilia (6 August 2020). "2 ecuatorianos, cerca del medicamento contra el Covid-19". YouTube. Archived from the original on 2021-12-21. Retrieved 13 October 2020.